checkpoint inhibitors Posts on Medivizor

Posted by Kathleen Hoffman on May 26, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Lung cancer, Melanoma, Prostate cancer | 2 comments

In July 2015, we published a post called Patients Included In Research: Studying Cancer by Mutation Not Organ.  In that post, we shared the goal that cancers would be treated not by the site of origin, but rather by their genetic features.  Achieving this goal is closer than you think! This week the FDA announced accelerated approval** of a...